IDO1 and rosacea: Odabasi et al. [33] assessed serum indoleamine 2,3-dioxygenase (IDO) in 52 patients with rosacea (36 females, 16 males; mean age not reported) and 29 healthy controls (21 females, 8 males; mean age not reported).